HYPERURICEMIA AS A RISK FACTOR FOR ARTERIAL HYPERTENSION AMONG THE POPULATION OF THE FERGANA REGION OF THE REPUBLIC OF UZBEKISTAN
Abstract
Today, a lot of data has been accumulated on the role of purine metabolism disorders in the development of several diseases, including cardiovascular diseases. However, the results of a large number of epidemiological and clinical studies aimed at detecting the pathogenetic relationship between hyperuricemia (HU) and arterial hypertension (AH) are contradictory. According to the purpose of the study - to study the epidemiological conditions in relation to hypertension in connection with HU and other risk factors in order to be able to plan multifactorial prevention on this basis , we carried out epidemiological study of hypertension due to a combination of risk factors such as HU, impaired carbohydrate tolerance (IHT), pesticidemia, dyslipoproteinemia (DLP), overweight and smoking among rural men and women of working age . We chose a continuous method of epidemiological examination with the measurement of blood pressure, ECG, anthropometric and biochemical studies. To determine the groups for primary, secondary and tertiary prevention, we have established the level of individual risk of developing hypertension. On this basis, a percentile distribution was built and the entire population of men and women was divided into 3 groups: 1-group of moderate risk (84.6%); 2-high-risk group (10.3%) and 3-group of patients (5.1%).
References
- References:
- Bilchenko A. V. Hyperuricemia as a risk factor for cardiovascular morbidity and mortality
- / A.V.Bilchenko // Russian Medical Journal. –2009. – No. 10. – P. 46–48.
- Mychka V. B. Recommendations of experts of the All-Russian Society of Cardiology for the diagnosis and treatment of metabolic syndrome (second revision) / V. B. Mychka, Yu. V. Zhernakova , I. E. Chazova // Doctor.
- ru . - 2010. - No. 3. - P. 15–18.
- Tashkenbayeva E.N. Asymptomatic hyperuricemia, pathogenetic aspects, clinical prediction and correction / E. N. Tashkenbayeva , A. L. Alyavi , D. Kh. Togaev . - Tashkent: FAN, 2014. - 176 p.
- Tashkenbayeva E. N. Hyperuricemia in pathogenesis, clinic of the metabolic syndrome and the development of cardiovascular complications: dissertation for the degree / E. N. Tashkenbayeva . - Tashkent, 2010. - 216 p.
- Clinical significance of hyperuricemia and uric acid metabolism in the pathology of the cardiovascular system / B. G. Khodzhakuliyev , G. O. Begencheva , D. M. Akhmedova [et al.] // Young scientist. - 2014. - No. 18.
- - S. _ 178-184.
- Hyperuricemia as a risk factor for target organ damage and the possibility of its drug correction in patients with metabolic syndrome. The topic of the dissertation and abstract on the Higher Attestation Commission of the Russian Federation 14.01.04, Candidate of Sciences Chumachek , Elena Valerievna
- Dubchak , N. New and improved strategies for the treatment of gout / N.Dubchak , G. Falasca // Int J Nephrol Reno vase Dis. - 2010. - No. 3. -P.145-166.
- Choi HK Independent impact of gout on mortality and risk for coronary heart disease / HK Choi, G. Curhan// Circulation n. - 2007. - No. 116. - R. 894-900.
- ESH/ESC Guidelines for management of arterial hypertension 2013 // European Heart Journal. - 2013. - No. 28. -P.2159-2219.
- Hsu, CY Risk factors for end-stage renal disease: 25-year follow-up / CYHsu , C.Iribarren , CEMcCulloch , J.Darbinian , ASGo // Arch Intern Med. - 2009. - No. 4. - P.342-350.
- Obermayr , R. Elevated Uric Acid Increases the Risk for Kidney Disease / R. Obermayr , C. Temml , G. Gutjahr , M. Knechtelsdorfer , R. Oberbauer , R. Klauser- Braun // Am Soc Nephrol . - 2008. - No. 12. - P.2407-2413.
- Oda, E. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men / E. Oda , R. Kawai , V. Sukumaran , K. Watanabe // Intern Med. - 2009. - No. 48. - P.1785-1791.